FDA Drugs (New Approvals & NDA)Original article
Boothwyn Pharmacy, LLC - 717525 - 01/16/2026
RegulatoryNegative
AI Analysis
Summary
Boothwyn Pharmacy, LLC (FDA establishment ID 717525) was cited by the FDA on January 16, 2026 for issues related to compounding pharmacy operations and adulterated drug products.
Outcome Details
FDA warning regarding compounding pharmacy and adulterated drug products
Importance:3/10
Sentiment:
-0.70
FDAcompounding pharmacyadulterated drugsregulatory actioncompliance
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 28, 2026 5:06 PM
